Report Highlights
The U.S. market for medical automation technologies will grow from nearly $16.3 billion in 2014 to $17.5 billion by 2015. This market should reach nearly $26.5 billion by 2020, demonstrating a compound annual growth rate (CAGR) of 5.1% between 2015 and 2020.
Report Includes
- An overview the global medical automation market, its products, and technologies.
- Analysis of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Coverage of medical automation applications, enabling technologies, and end user segments.
- Information on the market's environment: legal and regulatory, standards, economic conditions, consumer attitudes.
- Detailed analyses of:
- Automated health assessment and monitoring technologies.
- Automated medical imaging and image analysis.
- Automated prescription fulfillment devices.
- Automated therapeutic (nonsurgical) devices.
- Robotic and computer-assisted surgical equipment.
- Automated laboratory testing and analysis.
- Automated healthcare logistics, resource, and patient tracking.
- Automated medical training.
- Profiles of major players in the medical automation market.
Report Scope
As indicated above, medical automation is closely related to healthcare IT, which is the subject of a companion BCC Research report, HLC048D Healthcare Information Technology. However, for the purposes of this report, medical automation technologies are defined as technologies for the electromechanical control or operation of diagnostic or therapeutic processes or systems or training of healthcare professionals, and which result in a reduced need or eliminate the need for human intervention. Examples of such medical automation technologies are:
- Automated health assessment and monitoring technologies.
- Automated medical imaging and image analysis.
- Automated prescription fulfillment devices.
- Automated therapeutic (nonsurgical) devices.
- Robotic and computer-assisted surgical equipment.
- Automated laboratory testing and analysis.
- Automated healthcare logistics, resource and patient tracking.
- Automated medical training.
The study format includes the following major elements:
- Executive summary.
- Definitions.
- Medical automation technologies and applications.
- Enabling technologies.
- End-user segments.
- Market environment (legal and regulatory, standards, economic conditions, consumer attitudes).
- Baseline (2014) and projected market for medical automation technologies and products through 2020.
Analyst Credentials
Andrew McWilliams spent more than 25 years as a consultant with Ernst & Young, McKinsey & Company and A.T. Kearny focused on manufacturing before segueing into research analysis. He has been covering myriad technology categories for BCC Research for more than 15 years. McWilliams has a BA from Princeton University and an MA from Harvard University. He has worked in more than 40 countries and he resides in the greater Boston area.
Report Highlights
The U.S. market for medical automation technologies was worth an estimated $13 billion in 2010. BCC expects this market to grow to $13.3 billion in 2011 and $21 billion by 2016, a compound annual growth rate (CAGR) of 9.5% over the next 5 years.
Report Highlights
- The U.S. market for medical automation technologies was worth an estimated $12 billion in 2008. This market is projected to grow to $13.1 billion in 2009 and to $23.2 billion by 2014, a compound annual growth rate (CAGR) of 12.2% over the next 5 years.
- Therapeutic applications account for the largest share of the medical automation market, with 73% in 2008, declining slightly to 72% by 2014.
- Diagnostic and monitoring applications represent about a quarter of the market, with $3 billion in sales in 2008. That is expected to rise to $3.3 billion in 2009 and to nearly $5.9 billion in 2014, for a CAGR of 12.4%.
Related Reports
Healthcare Information Technology
The U.S. market for clinical healthcare information technologies reached $14.1 billion and nearly $15.6 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 4.8% to reach $19.7 billion in 2019.
The Market for Minimally Invasive Medical Devices
The global market for MIS devices and equipment was about $14.5 billion in 2013. This market reached about $15.4 billion in 2014 and is expected to reach $21.5 billion in 2019, registering a compound annual growth rate (CAGR) of 6.8% for the period 2014-2019.
Global Markets for Telemedicine Technologies
The global telehospital/clinic and telehome market reached $16.3 billion in 2013 and $19.2 billion in 2014, and should reach about $43.4 billion in 2019 with a compound annual growth (CAGR) of 17.7% through 2019.
Medical Robotics and Computer-Assisted Surgery: The Global Market
The global market for medical robotics and computer-assisted surgical (MRCAS) equipment was worth nearly $2.7 billion in 2013. The market is projected to approach $3.3 billion in 2014 and $4.6 billion by 2019 for a CAGR of 7% for the five-year period, 2014 to 2019.
Recent Reports
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
Infusion Pumps and Devices: Technologies and Global Markets
The global market for infusion pumps is expected to grow from $10.1 billion in 2024 and is projected to reach $14.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% during the forecast period of 2024 to 2029.
Top Trending Reports
Point-of-Care Diagnostics: Technologies and Global Markets
The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.
AI in Clinical and Molecular Diagnostics Market
The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Artificial Intelligence (AI) Market: Investments vs Potential
The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.
Global Oncology Pharmaceuticals Market
The global market for oncology pharmaceuticals is estimated to increase from $196.4 billion in 2023 to reach $401.4 billion by 2029, at a compound annual growth rate (CAGR) of 12.7% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More